Literature DB >> 4087086

Urinary extravasation in the fetus with obstructive uropathy.

N S Adzick, M R Harrison, A W Flake, A A deLorimier.   

Abstract

Urinary extravasation resulting in either urinary ascites or an isolated perirenal urinoma is relatively common in the fetus with severe obstructive uropathy. We examined the effect of fetal urinary extravasation on the developing kidney and abdominal wall in 12 fetuses taken from a series of 44 cases of fetal urinary tract obstruction. Based on this experience, we conclude that fetal urinary extravasation has predictable pathophysiologic consequences. Fetal urinary ascites appears to ameliorate obstruction-induced renal dysplasia by decompressing the high-pressure, obstructed fetal urinary system. Conversely, contained urinomas secondary to ureteropelvic junction obstruction provide inadequate decompression and are associated with renal dysplasia. Last, the severity of abdominal wall laxity (prune belly) relates directly to the timing and degree of fetal ascites.

Entities:  

Mesh:

Year:  1985        PMID: 4087086     DOI: 10.1016/s0022-3468(85)80008-7

Source DB:  PubMed          Journal:  J Pediatr Surg        ISSN: 0022-3468            Impact factor:   2.545


  4 in total

1.  Spontaneous perinephric urinoma in pregnancy.

Authors:  K Hamoud; J Kaneti; Z Smailowitz; D Kroll; Y Barki
Journal:  Int Urol Nephrol       Date:  1994       Impact factor: 2.370

2.  Neonatal urinary ascites due to unilateral vesicoureteric junction obstruction.

Authors:  K E Chun; R S Ferguson
Journal:  Pediatr Surg Int       Date:  1997-07       Impact factor: 1.827

3.  Fetal urinoma and prenatal hydronephrosis: how is renal function affected?

Authors:  Tayfun Oktar; Emre Salabaş; İbrahim Kalelioğlu; Arda Atar; Haluk Ander; Orhan Ziylan; Recep Has; Atıl Yüksel
Journal:  Turk J Urol       Date:  2013-06

4.  Urinary ascites in infancy: varied etiologies.

Authors:  A M Checkley; A J Sabharwal; G A MacKinlay; F D Munro; J D Orr
Journal:  Pediatr Surg Int       Date:  2003-05-10       Impact factor: 1.827

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.